Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612313 · ClinicalTrials.gov registry record · NA
Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT00612313 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 144 participants.
The verdict
NCT00612313, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of fluoxetine alone with the effectiveness of fluoxetine with cognitive behavioral therapy in increasing recovery and preventing relapse in youth with major depressive disorder.
Interventions
- DRUG Fluoxetine
- BEHAVIORAL Relapse prevention cognitive behavioral therapy (CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612313
The ClinicalTrials.gov registry entry for NCT00612313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluoxetine is the first listed.
NCT00612313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612313 about?
NCT00612313 is a clinical study titled "Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse". This study will compare the effectiveness of fluoxetine alone with the effectiveness of fluoxetine with cognitive behavioral therapy in increasing recovery and preventing relapse in youth with major depressive disorder.
What is the current status of trial NCT00612313?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2008-02. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00612313?
The interventions under investigation include: Fluoxetine (DRUG), Relapse prevention cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00612313?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.